VisionCare Ophthalmic Technologies

Bookmark

Add to MyYahoo RSS

VisionCare Ophthalmic Technologies News

News on VisionCare Ophthalmic Technologies (Ticker: JNJ) continually updated from thousands of sources around the net.

4 hrs ago | Seeking Alpha

Johnson & Johnson: Slow And Steady Core Holding, But No Discount Here

Johnson & Johnson offers investors a diverse product line, robust free cash flow generation, reliable dividend growth, and low volatility suitable for a core holding. Though the company outperformed expectations in the most recent quarter, yearly sales growth has slowed in recent years as patent expirations cut into revenues.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Tue Sep 16, 2014

Seeking Alpha

Steer Clear Of Viking Therapeutics' IPO

VKTX, a clinical-stage biopharmaceutical firm developing treatments for metabolic and endocrine disorders, plans to raise $55.0 million in its upcoming IPO. Though VKTX does have a broad portfolio of product candidates, none of them are any where near the point of commercialization.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Sun Sep 14, 2014

Adweek

MasterChef Finalist Explains the Crossover Between Cooking and Advertising

When she was auditioning for Season 5 of Fox's hit cooking show MasterChef, Elizabeth Cauvel told producers she was an associate creative director at New York-based ad agency MRY, working on Johnson & Johnson brands like Listerine and Band-Aid. Their response: blank stares all around.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Johnson, NY, Startups, Television

Thu Sep 11, 2014

PR-inside.com

New Report Available: Janssen Research & Development, LLC -...

Janssen Research & Development , a subsidiary of Johnson and Johnson is a pharmaceutical company. The company discovers and develops innovative medicines that ease patients suffering and solve most important unmet medical needs.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Wed Sep 10, 2014

Daily Kos

A House of Cards for Pelvic Mesh?

A House of Cards: How consecutive multi-million dollar verdicts spell the beginning of the end for the pelvic mesh industry Last Friday, a West Virginia jury awarded $3.27 million to an Illinois woman in her case against industry giant Johnson & Johnson over her pelvic mesh implant, a controversial medical device that allegedly resulted in permanent nerve damage, chronic pain, and caused the former athlete trouble with walking, among other symptoms.

Comment?

Related Topix: Healthcare Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, OrthoClinical Diagnostics, Medical Equipment

Seeking Alpha

Johnson & Johnson's Management Presents at 2014 Morgan Stanley Health Care Conference

Good morning. It's a, sorry. So find your seats here. It's our pleasure to have this year this morning management team members from Johnson & Johnson, specifically the Chief Financial Officer, Dominic Caruso; so Stan Panasewicz, Senior Director of Investor Relations, obviously, you maybe know Stan.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Startups, Scios

Tue Sep 09, 2014

TheStreet.com

Johnson & Johnson Should Ignore Those Breakup Calls

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

BioSpace

Johnson & Johnson Release: Pioneering Gene Editing Research...

Johnson & Johnson Release: Pioneering Gene Editing Research Celebrated This Week During 2014 Dr. Paul Janssen Award for Biomedical Research Events /PRNewswire/ -- This week, Johnson & Johnson will host events to celebrate the work of the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research . Drs. will be honored for their breakthrough discovery of the CRISPR-Cas9 method of genetic editing that has led to a substantial leap in scientists' ability to manipulate genetic processes and has the potential to make a significant impact on drug development and treatment of human genetic disorders.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

BioSpace

Johnson & Johnson Release: Pioneering Gene Editing Research...

Johnson & Johnson Release: Pioneering Gene Editing Research Celebrated This Week During 2014 Dr. Paul Janssen Award for Biomedical Research Events /PRNewswire/ -- This week, Johnson & Johnson will host events to celebrate the work of the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research . Drs. will be honored for their breakthrough discovery of the CRISPR-Cas9 method of genetic editing that has led to a substantial leap in scientists' ability to manipulate genetic processes and has the potential to make a significant impact on drug development and treatment of human genetic disorders.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

TheStreet.com

Johnson & Johnson Should Ignore Those Breakup Calls

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Seeking Alpha

Johnson & Johnson: The One Stock You Should Ever Own?

The company's pharmaceutical unit is most likely to exceed expectations as it launches multiple new drug compounds, including its high-profile hepatitis C drug, Olysio. Management has been and will continue to divest business units that do not meet their standards for sufficient revenue and profit growth.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Advanced Transit Dynamics, Startups

Mon Sep 08, 2014

Seeking Alpha

Achillion - An Options Strategy For A Potential Acquisition

When Merck acquired Idenix in early June for its nucleotide NS5B polymerase inhibitor, investors anticipated Achillion would soon also be acquired. The outcome of the small Phase 1B study with its nucleotide NS5B drug candidate in HCV patients, expected in fall 2014, will be a binary event for Achillion.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Advanced Transit Dynamics, Startups

Medical News

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider in Europe, the Middle East and Africa. PulseRider is a minimally invasive device intended for use with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Fri Sep 05, 2014

Bloomberg

J&J Ordered to Pay $3.27 Million Over Mesh Implant

Johnson & Johnson was ordered by a jury to pay $3.27 million to a woman who said a defectively designed vaginal-mesh implant eroded inside her and she had to have surgery. Jurors in federal court in West Virginia today concluded J&J's Ethicon unit was liable for Jo Huskey's injuries, which she blamed on the company's TVT-O mesh sling, according to the company.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

TheStreet.com

Will This Ratings Initiation Help Johnson & Johnson (JNJ) Stock Today?

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Thu Sep 04, 2014

Medical News

Codman Neuro launches Revive Se Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration , South Korea's Ministry of Food and Drug Safety , and the Taiwan Food and Drug Administration for the company's REVIVE SE Thrombectomy Device, a next-generation self-expanding clot removal device intended to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease. The REVIVE SE Device is designed to ease navigation through small and tortuous blood vessels and arteries in the cerebral vasculature.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

The Alternative Press

Powers Makes Journey from Scientist to Novelist via 'The Pharm House'

Bill Powers, a resident of Mendham went from leading groups of scientists in the United States, Europe, and Asia, to pursuing his passion of being a fictional author. Powers debuted his modern mystery, "The Pharm House," a year ago, which took almost 10 years to publish.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Wed Sep 03, 2014

CBC News

Ebola outbreak: Johnson & Johnson get OK to fast-track vaccine trials

Crucell's headquarters in Leiden, Netherlands are shown in this file photo. The vaccine Johnson & Johnson will be testing was developed at Crucell.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Investor's Business Daily

Sharper Focus Pays Dividends At Johnson & Johnson

Judging by its Q2 earnings report, the strategy seems to be working. In July, the company and Dow industrials component reported strong second-quarter earnings.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Advanced Transit Dynamics, Startups

Business World

Google is Ireland's No 1 exporter

Google Ireland is Ireland's top exporter with Microsoft coming in at No 2, according to the Top 250 Exporters in Ireland and Northern Ireland from the Irish Exporters Association and Investec.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••